Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review

• DOI: 10.1111/cup.14605
• Publication Date: 2024-03-06T06:35:21Z
• Authors: Haneen T. Salah; Richard K. Yang; Sinchita Roy‐Chow...; Merrick I. Ross; Phyu P. Aung; Aimi T. Rothrock; Carlos A. Torres‐...; Jonathan L. Curry; Victor G. Prieto; Priyadharsini Nag...; Woo Cheal Cho
• Keywords: Male; Adult; 0301 basic medicine; 03 medical and health sciences; Skin Neoplasms; Oncogene Proteins, Fusion; Nevus, Epithelioid and Spindle Cell; Humans; Anaplastic Lymphoma Kinase; Female; Melanoma; Adaptor Proteins, Signal Transducing

AbstractALK‐fused Spitz melanocytic neoplasms are a distinct subgroup of melanocytic lesions exhibiting unique histopathologic characteristics. These lesions often manifest as exophytic or polypoid tumors, characterized by fusiform‐to‐epithelioid melanocytes arranged in a nested, fascicular, or plexiform growth pattern. Several fusion partners of the ALK gene have been identified in spitzoid melanocytic neoplasms, with TPM3 and DCTN1 being the most prevalent. Less common fusion partners include NPM1, TPR, CLIP1, GTF3C2, EEF2, MYO5A, KANK1, and EHBP1. The MLPH gene, which encodes melanophilin (MLPH), playing a crucial role in regulating skin pigmentation by acting as a linker between RAB27A and myosin Va during melanosome transport, has also recently been recognized as a rare fusion partner of ALK in Spitz melanocytic neoplasms. Currently, there exists a sparse documentation within English literature, illustrating a limited number of cases featuring MLPH::ALK fusion in Spitz melanocytic neoplasms. In this report, we present two additional cases, including a previously unreported instance of Spitz melanoma, contributing to the expanding knowledge on ALK‐fused Spitz melanocytic neoplasms. In addition, we provide a comprehensive review of the clinical, histopathologic, and molecular features observed in documented cases with this novel fusion.